RECURSION PHARMACEUTICALS, INC.·4

May 17, 7:12 PM ET

Mauro David J 4

4 · RECURSION PHARMACEUTICALS, INC. · Filed May 17, 2024

Insider Transaction Report

Form 4
Period: 2024-05-15
Mauro David J
Chief Medical Officer
Transactions
  • Tax Payment

    Class A Common Stock

    2024-05-15$10.01/sh867$8,679243,762 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $10.09Exp: 2034-02-09Class A Common Stock (0 underlying)
    99,537
  • Stock Option (Right to Buy)

    Exercise: $8.77Exp: 2033-06-01Class A Common Stock (0 underlying)
    381,426
Footnotes (3)
  • [F1]Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
  • [F2]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
  • [F3]This option vests as to one fourth (1/4th) of the shares subject to the option on June 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter subject to Reporting Person's continued service to the Issuer through each such vesting date.

Documents

1 file
  • 4
    wk-form4_1715987513.xmlPrimary

    FORM 4